NASDAQ Equity Snapshot
GNLX Weekly Equity Report
Genelux Corporation Common Stock
What the company does
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. The company is headquartered in Westlake Village, California.
What the weekly tape is saying
GNLX closed the latest completed week at 2.96 USD. The 4-week return is 1.4% and the 12-week return is 23.3%. Trend Signal is inactive, Market Dynamics is 0.45. Setup signature: Risk-first tape with a 30/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 3.18 USD
- Vs Trend Line
- -7.0%
- Fair Value
- 6.88 USD
- Vs Fair Value
- -57.0%
- 52W High
- 8.54 USD
- 52W Low
- 2.29 USD
- Drawdown
- -65.3%
- Range Position
- 10.7%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 16
- 52W Active Breadth
- 30.8%
- Sector Scope
- US Healthcare
- Sector Rank
- 470 of 1038
- Sector Percentile
- 54.8%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
US Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 0.8%
- Avg 4W
- 3.5%
- Trend Breadth
- 33.0%
- Positive MD
- 41.0%
US Biotechnology
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 4.9%
- Avg 4W
- 1.7%
- Trend Breadth
- 46.0%
- Positive RS
- 47.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.45
- 4W MD Change
- 12.9%
- Relative Strength
- -31.64
- 4W RS Change
- 1.9%
- Expectation
- Undecided
- Probability
- 45.94%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 657.7K
- 13W Average
- 906.6K
- 52W Average
- 935.1K
- Vs 13W
- 0.7x
- Vs 52W
- 0.7x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 6.7%
- 52W Volatility
- 11.6%
- Upside Weeks
- 29
- Downside Weeks
- 22
- Downside Breadth
- 42.3%
- Avg Gain / Loss
- 7.9% / -8.9%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NASDAQ
- Country
- US
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
- Market Cap
- 136.8M
Opportunity signals
- Market Dynamics is positive on the latest completed week.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 2.96 USD | 1.0% | 3.18 USD | 6.88 USD | 0.45 | -31.64 | 657.7K | Off |
| 5 Jun 2026 | 2.93 USD | -3.9% | 3.26 USD | 7.08 USD | 0.52 | -31.16 | 894.1K | Off |
| 29 May 2026 | 3.05 USD | 4.5% | 3.35 USD | 7.24 USD | 0.58 | -31.72 | 659.5K | Off |
| 22 May 2026 | 2.92 USD | 0.0% | 3.51 USD | 7.41 USD | 0.48 | -32.85 | 532.9K | Off |
| 15 May 2026 | 2.92 USD | -6.1% | 3.68 USD | 7.54 USD | 0.40 | -32.26 | 1.1M | Off |
| 8 May 2026 | 3.11 USD | 13.5% | 3.77 USD | 7.69 USD | 0.28 | -28.23 | 986.4K | Off |
| 1 May 2026 | 2.74 USD | 8.7% | 3.84 USD | 7.83 USD | 0.09 | -33.65 | 653.8K | Off |
| 24 Apr 2026 | 2.52 USD | -9.7% | 3.89 USD | 7.98 USD | -0.08 | -38.30 | 703.7K | Off |
| 17 Apr 2026 | 2.79 USD | 9.8% | 3.95 USD | 8.12 USD | -0.22 | -30.61 | 886.9K | Off |
| 10 Apr 2026 | 2.54 USD | -1.2% | 3.99 USD | 8.29 USD | -0.52 | -33.26 | 1.9M | Off |
| 2 Apr 2026 | 2.57 USD | 3.6% | 4.04 USD | 8.45 USD | -0.79 | -29.74 | 694.0K | Off |
| 27 Mar 2026 | 2.48 USD | 3.3% | 4.07 USD | 8.61 USD | -0.94 | -29.78 | 1.2M | Off |
| 20 Mar 2026 | 2.40 USD | -7.7% | 4.10 USD | 8.77 USD | -1.04 | -34.68 | 898.1K | Off |
| 13 Mar 2026 | 2.60 USD | -4.1% | 4.14 USD | 8.95 USD | -1.14 | -31.48 | 522.4K | Off |